Switzerland has increased its coronavirus vaccine order with Moderna by three million doses. This Alpine country now has 15.8 million doses of vaccines on order from three different manufacturers, pending approval from the health regulator.
This content was published on
2 minutes
swissinfo.ch/mga
The Swiss government increased its previous order with the US biotechnology company for its mRNA vaccine to a new total of 7.5 million doses, it was announced on Tuesday. Earlier this week, Switzerland added a vaccine from Pfizer/BioNTech to its desired stockpile list.
Switzerland’s membership of the World Health Organization COVAXExternal link initiative would also grant access to enough vaccines to cover 20% of the Swiss population.
Health regulator Swissmedic is currently evaluating the safety of several vaccine candidates under its “rolling procedure”, which allows manufacturers to submit the results of test studies in stages. So far, no vaccine has yet been approved.
On Wednesday, Swiss pharmaceutical giant Roche said it had reached an agreement with Moderna to extend the use of its Elecsys Anti-SARS-CoV-2 Sdiagnostic tool to speed up testing of its vaccine.
“To enhance our understanding of vaccines against SARS-CoV-2 there would be a benefit in knowing the starting levels of antibodies a person has, prior to vaccination, in order to evaluate any change in antibody levels that the vaccine induces,” Roche stated in a press release.
The Elecsys Anti-SARS-CoV-2 Sdiagnostic tool was granted emergency use authorisation by the US health authorities last month.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Switzerland Tourism takes stock of three years of pandemic recovery
This content was published on
2023 saw an unprecedented number of overnight guests, suggesting that the industry has been able to bounce back through additional funding, marketing and development.
This content was published on
The bank's CEO acknowledges that the institution is "too big to fail." There is however disagreement with certain of the proposed regulations.
Employees in Switzerland increasingly stressed at work
This content was published on
The proportion of people in Switzerland who are stressed at work has increased by 5% over ten years, according to the Federal Statistical Office.
This content was published on
F/A-18 fighter jets will practice take offs and landings on the A1 motorway between Payerne and Avenches in canton Vaud on June 5.
Swisscom finalises financing for Vodafone Italia takeover
This content was published on
Telecoms group Swisscom has taken the next step in its takeover of Vodafone Italia and secured financing for the deal, the company said on Thursday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Incomplete data stalls Swiss authorisation of Covid-19 vaccines
This content was published on
Switzerland’s medical regulator says it lacks the necessary information to sign off on three different vaccines ordered by the government.
Switzerland secures three million doses of Pfizer/BioNTech vaccine
This content was published on
Some 4.5 million doses of another vaccine have already been agreed with United States pharma company Moderna and another 5.3 million doses from the British-Swedish firm AstraZeneca. The government said on MondayExternal link that membership of the World Health Organization COVAXExternal link initiative grants vaccine coverage to 20% of the Swiss population. The Pfizer/BioNTech vaccine would require…
This content was published on
With a death toll of over 5,000, Switzerland (population 8.5 million) expects to launch its coronavirus vaccination campaign in early January.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.